Medically reviewed by Qin Rao, MD Metabolic dysfunction-associated steatohepatitis (MASH)—previously known as nonalcoholic ...

Driven by rising levels of obesity, NASH causes fibrosis and swelling in the liver and has become a leading concern in healthcare as increasing numbers of people with the condition advance to ...

Over time, NASH causes scar tissue formation, which in many cases leads to liver cirrhosis and related serious complications, including liver failure or liver cancer.

Madrigal Pharmaceuticals has been given Food and Drug Administration market clearance for its experimental treatment for NASH ...